Together, this data indicates that oxidation of C200/344 of PRKACB enhances PKA kinase activity to enable RNF25 phosphorylation and ECAD degradation, ECAD degradation subsequently induces migration and invasion of HCC cells. Here, PRKACB is linked to hepatocellular carcinoma.